Skip to main content

Find Clinical Trials

Home
Conditions
Parathyroid Carcinoma

Clinical trial condition

Parathyroid Carcinoma

Explore clinical trials studying Parathyroid Carcinoma. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Parathyroid Carcinoma trial results

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations: Hospital São Carlos Fortaleza, Ceará, Brazil

Hospital São Rafael Salvador, Estado de Bahia, Brazil

Hospital Santa Cruz Curitiba, Paraná, Brazil

IDOR Recife Recife, Pernambuco, Brazil

View Trial Details

Enrolling by Invitation

PET-TC in Thyroid Evaluation

NCT06852144

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
Locations: Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di Bologna Bologna, Bo, Italy

View Trial Details

Completed

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

NCT03280264

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +8 more
Locations: Osaka City University Hospital Ōsaka, Japan

View Trial Details

Completed

Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior

NCT03046524

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +6 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

NCT01460030

Conditions: Calcium Metabolism Disorders, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Sendai, Japan

View Trial Details

Completed

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

NCT00580320

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoid Tumor, +32 more
Locations: Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States

Massey Cancer Center/Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details